CISPLATIN, TAGRISSO 40 mg film-coated tablets, Datopotamab deruxtecan, TAGRISSO 80 mg film-coated tablets, CARBOPLATIN, PEMETREXED
D516KC00001
Phase 3 small_molecule active
Quick answer
CISPLATIN, TAGRISSO 40 mg film-coated tablets, Datopotamab deruxtecan, TAGRISSO 80 mg film-coated tablets, CARBOPLATIN, PEMETREXED for Non squamous non-small cell lung cancer (NSCLC) is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Non squamous non-small cell lung cancer (NSCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active